ArticleCell death & disease2025

MCL-1 as a molecular switch between myofibroblastic and pro-angiogenic features of breast cancer-associated fibroblasts.

Chloé C Lefebvre et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.